Factory best selling Oxytetracycline 250 - Albendazole Suspension – Xinanran
Factory best selling Oxytetracycline 250 - Albendazole Suspension – Xinanran Detail:
Main ingredient
Albendazole
Characteristics
A suspension solution of fine particles，When standing still, the fine particles precipitates. After shaking thoroughly， it is a uniform white or white-like suspension.
Pharmacological action
An antiparasitic drug. Albendazole has a broad-spectrum repellent effect, which is sensitive to nematodes, tapeworms and trematodes, but is not effective against schistosoma. The mechanism of its action is that it binds to β-tubulin in nematodes and prevents it from polymerizing with β-tubulin to form microtubules, thus affecting mitosis, protein assembly, energy metabolism and other cell reproductive processes in nematodes. This product not only has a strong effect on adult worms, but also has a strong effect on immature worms and larvae, and has the effect of killing eggs. Albendazole has a significantly higher affinity for nematode tubulin than mammalian tubulin and thus has little mammalian toxicity.
Hebei Xinanran Biology Science And Technology Co., Ltd.
Address: No. 06, East Row 1, Konggang Street, Xinle Economic Development Zone, Hebei Province
Tel: 0311-85695628/85695638
Postcode: 050700
Product detail pictures:
Related Product Guide:
Our growth depends to the superior products ,great talents and repeatedly strengthened technology forces for Factory best selling Oxytetracycline 250 - Albendazole Suspension – Xinanran , The product will supply to all over the world, such as: Oman, Spain, Naples, Further, we are supported by highly experienced and knowledgeable professionals, who have immense expertise in their respective domain. These professionals work in close coordination with each other to offer our clients an effective range of products.
By Bertha from Costa rica - 2017.06.19 13:51
The after-sale warranty service is timely and thoughtful, encounter problems can be resolved very quickly, we feel reliable and secure.
By Ida from South Africa - 2017.10.23 10:29
